Trial intelligence / Profile preview

Oliceridine plus esketamine PCIA in elderly colorectal cancer surgery

ChiCTR2500115708Phase 4Completed

Sponsor
Huaihe Hospital of Henan University
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in colorectal cancer (CRC) and postoperative pain comparing Oliceridine PCIA, Esketamine PCIA and Oliceridine + esketamine PCIA (3 arms). Primary endpoint: Postoperative active pain score during coughing. Started Dec 2025; status: completed.

02

Drugs

oliceridineesketamine
03

Conditions

colorectal cancer (CRC)postoperative pain

Beyond the preview

Go deeper on ChiCTR2500115708.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500115708.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call